In 2023, the mortality rate for ovary malignant neoplasms in Brazil stood at an estimated 3.9 deaths per hundred thousand women. The forecast data from 2024 to 2028 indicates a gradual increase in mortality rates, rising from 4.0 to 4.3 by 2028. Annually, there is an incremental rise of approximately 0.1 units, leading to an average annual growth rate (CAGR) of approximately 2.5% over five years.

Future trends to watch for:

Advancements in early detection and treatment methods could potentially alter these forecasts.
Healthcare policy changes focused on cancer prevention and management might impact future mortality rates.
Socioeconomic and demographic changes could influence health outcomes related to ovarian cancer.